Lead Product(s) : Arachidonic Acid
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Undisclosed
Sponsor : National Liver Institute, Egypt | Cairo University | High Institute of Public Health, Egypt
Deal Size : Inapplicable
Deal Type : Inapplicable
Arachidonic Acid Treatment Against Schistosomiasis Infection in Children
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
May 22, 2014
Lead Product(s) : Arachidonic Acid
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Undisclosed
Sponsor : National Liver Institute, Egypt | Cairo University | High Institute of Public Health, Egypt
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Arachidonic Acid
Therapeutic Area : Undisclosed
Study Phase : Phase I
Sponsor : Mead Johnson Nutrition
Deal Size : Inapplicable
Deal Type : Inapplicable
Assessment of Arachidonic Acid Supplementation in Infant Formula on the Immune Response of Infants
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
March 20, 2014
Lead Product(s) : Arachidonic Acid
Therapeutic Area : Undisclosed
Highest Development Status : Phase I
Sponsor : Mead Johnson Nutrition
Deal Size : Inapplicable
Deal Type : Inapplicable